Skip to main content

Articles

Page 275 of 324

  1. iASPP is a key inhibitor of tumour suppressor p53 and is found to be up-regulated in certain malignant conditions. The present study investigated the expression of iASPP in clinical lung cancer, a leading canc...

    Authors: Jinfeng Chen, Fei Xie, Lijian Zhang and Wen G Jiang
    Citation: BMC Cancer 2010 10:694
  2. Dexamethasone has been reported to reduce postoperative symptoms after different surgical procedures. We evaluated the efficacy of preoperative dexamethasone in ameliorating postoperative nausea and vomiting (...

    Authors: Jorge Gómez-Hernández, Alba Lorena Orozco-Alatorre, Marisela Domínguez-Contreras, Antonio Oceguera-Villanueva, Salvador Gómez-Romo, Andrea Socorro Alvarez Villaseñor, Clotilde Fuentes-Orozco and Alejandro González-Ojeda
    Citation: BMC Cancer 2010 10:692
  3. The Oncotype DX® Colon Cancer Assay is a new diagnostic test for determining the likelihood of recurrence in stage II colon cancer patients after surgical resection using fixed paraffin embedded (FPE) primary col...

    Authors: Kim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar and Drew Watson
    Citation: BMC Cancer 2010 10:691
  4. The amino-acid balance in cancer patients often differs from that in healthy individuals, because of metabolic changes. This study investigated the use of plasma amino-acid profiles as a novel marker for scree...

    Authors: Jun Maeda, Masahiko Higashiyama, Akira Imaizumi, Tomio Nakayama, Hiroshi Yamamoto, Takashi Daimon, Minoru Yamakado, Fumio Imamura and Ken Kodama
    Citation: BMC Cancer 2010 10:690
  5. We evaluate the long-term survival of patients with peritoneal carcinomatosis (PC) treated with systemic chemotherapy regimens, and the impact of the of the retrospective peritoneal disease severity score (PSD...

    Authors: Joerg OW Pelz, Terence C Chua, Jesus Esquivel, Alexander Stojadinovic, Joerg Doerfer, David L Morris, Uwe Maeder, Christoph-Thomas Germer and Alexander G Kerscher
    Citation: BMC Cancer 2010 10:689
  6. Old age at diagnosis is associated with poor survival in colorectal cancer (CRC) for unknown reasons. Recent data show that colonoscopy is efficient in preventing left-sided cancers only. We examine the associ...

    Authors: Kari Hemminki, Irene Santi, Marianne Weires, Hauke Thomsen, Jan Sundquist and Justo Lorenzo Bermejo
    Citation: BMC Cancer 2010 10:688
  7. To date, there are no clinically reliable predictive markers of response to the current treatment regimens for advanced colorectal cancer. The aim of the current study was to compare and assess the power of tr...

    Authors: Wendy L Allen, Puthen V Jithesh, Gavin R Oliver, Irina Proutski, Daniel B Longley, Heinz-Josef Lenz, Vitali Proutski, Paul Harkin and Patrick G Johnston
    Citation: BMC Cancer 2010 10:687
  8. Polycomb Group (PcG) proteins are epigenetic silencers involved in maintaining cellular identity, and their deregulation can result in cancer. Expression of Mel-18 and Bmi-1 has been studied in tumor tissue, b...

    Authors: Margit LH Riis, Torben Lüders, Anne-Jorunn Nesbakken, Hilde S Vollan, Vessela Kristensen and Ida RK Bukholm
    Citation: BMC Cancer 2010 10:686
  9. Oral leukoplakia (OL) is the best-known potentially malignant disorder. A new binary system to grade dysplasia was proposed by WHO, but the biological significance in predicting malignant transformation risk i...

    Authors: Wei Liu, Yu-Feng Wang, Hai-Wei Zhou, Peng Shi, Zeng-Tong Zhou and Guo-Yao Tang
    Citation: BMC Cancer 2010 10:685
  10. Differentiation therapy has been shown effective in treatment of several types of cancer cells and may prove to be effective in treatment of glioblastoma multiforme, the most common and most aggressive primary...

    Authors: Xijun Liu, Jin-Ming Yang, Samuel S Zhang, Xin-Yuan Liu and David X Liu
    Citation: BMC Cancer 2010 10:684
  11. Targeting tumor vasculature is a strategy with great promise in the treatment of many cancers. However, anti-angiogenic reagents that target VEGF/VEGFR2 signaling have met with variable results clinically. Amo...

    Authors: Steven G Patten, Una Adamcic, Kristen Lacombe, Kanwal Minhas, Karolina Skowronski and Brenda L Coomber
    Citation: BMC Cancer 2010 10:683
  12. Gene expression of peripheral myelin protein 22 (PMP22) and the epithelial membrane proteins (EMPs) was found to be differentially expressed in invasive and non-invasive breast cell lines in a previous study. We ...

    Authors: Dan Tong, Georg Heinze, Dietmar Pils, Andrea Wolf, Christian F Singer, Nicole Concin, Gerda Hofstetter, Ingrid Schiebel, Margaretha Rudas and Robert Zeillinger
    Citation: BMC Cancer 2010 10:682
  13. Stable disease (SD) has ambiguous clinical significance for patients according to the dominant Response Evaluation Criteria in Solid Tumours (RECIST). The primary aims of the study were: (1) to clarify the cli...

    Authors: Lijie He, Yuee Teng, Bo Jin, Mingfang Zhao, Ping Yu, Xuejun Hu, Jingdong Zhang, Songbai Li, Yaling Gao and Yunpeng Liu
    Citation: BMC Cancer 2010 10:681
  14. The protein AGR2 is a putative member of the protein disulfide isomerase family and was first identified as a homolog of the Xenopus laevis gene XAG-2. AGR2 has been implicated in a number of human cancers. In pa...

    Authors: Erin L Maresh, Vei Mah, Mohammad Alavi, Steve Horvath, Lora Bagryanova, Emily S Liebeskind, Laura A Knutzen, Yong Zhou, David Chia, Alvin Y Liu and Lee Goodglick
    Citation: BMC Cancer 2010 10:680
  15. The pharmacotherapeutic treatment of patients with cancer is generally associated with multiple side-effects. Drug interactions and duplicate prescriptions between anti-cancer drugs or interactions with medica...

    Authors: Roelof WF van Leeuwen, Eleonora L Swart, Frits A Boom, Martin S Schuitenmaker and Jacqueline G Hugtenburg
    Citation: BMC Cancer 2010 10:679
  16. Prolactin is a polypeptide hormone responsible for proliferation and differentiation of the mammary gland. More recently, prolactin's role in mammary carcinogenesis has been studied with greater interest. Stud...

    Authors: Erika Ginsburg, Stefanie Alexander, Sarah Lieber, Sarah Tarplin, Luwanda Jenkins, Linda Pang, Christopher D Heger, Paul Goldsmith and Barbara K Vonderhaar
    Citation: BMC Cancer 2010 10:678
  17. Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) are promising cancer drugs currently in clinical trials in oncology, including APO866, CHS-828 and the CHS-828 prodrug EB1627/GMX1777, but cancer ce...

    Authors: Uffe H Olesen, Jakob G Petersen, Antje Garten, Wieland Kiess, Jun Yoshino, Shin-Ichiro Imai, Mette K Christensen, Peter Fristrup, Annemette V Thougaard, Fredrik Björkling, Peter B Jensen, Søren J Nielsen and Maxwell Sehested
    Citation: BMC Cancer 2010 10:677
  18. Hedgehog (HH) signaling is critical for the expansion of granule neuron precursors (GNPs) within the external granular layer (EGL) during cerebellar development. Aberrant HH signaling within GNPs is thought to...

    Authors: Joseph R Cohen, Daniel Z Resnick, Pawel Niewiadomski, Hongmei Dong, Linda M Liau and James A Waschek
    Citation: BMC Cancer 2010 10:676
  19. Hormone therapy plus radiotherapy significantly decreases recurrences and mortality of patients affected by locally advanced prostate cancer. In order to determine if difference exists according to the hormona...

    Authors: Federica Cuppone, Emilio Bria, Diana Giannarelli, Vanja Vaccaro, Michele Milella, Cecilia Nisticò, Enzo Maria Ruggeri, Isabella Sperduti, Sergio Bracarda, Paola Pinnarò, Gaetano Lanzetta, Paola Muti, Francesco Cognetti and Paolo Carlini
    Citation: BMC Cancer 2010 10:675
  20. Cancer chemotherapy is frequently associated with a decline in general physical condition, exercise tolerance, and muscle strength and with an increase in fatigue. While accumulating evidence suggests that phy...

    Authors: Hanna van Waart, Martijn M Stuiver, Wim H van Harten, Gabe S Sonke and Neil K Aaronson
    Citation: BMC Cancer 2010 10:673
  21. Aldo-keto reductase (AKR) 1C family member 3 (AKR1C3), one of four identified human AKR1C enzymes, catalyzes steroid, prostaglandin, and xenobiotic metabolism. In the prostate, AKR1C3 is up-regulated in locali...

    Authors: Mikhail G Dozmorov, Joseph T Azzarello, Jonathan D Wren, Kar-Ming Fung, Qing Yang, Jeffrey S Davis, Robert E Hurst, Daniel J Culkin, Trevor M Penning and Hsueh-Kung Lin
    Citation: BMC Cancer 2010 10:672
  22. The use of high-dose chemotherapy combined with autologous stem cell transplantation has improved the outcome of hematologic malignancies. Nevertheless, this treatment can cause persistent fatigue and a reduce...

    Authors: Saskia Persoon, Marie José Kersten, Mai JM ChinAPaw, Laurien M Buffart, Heleen Burghout, Goof Schep, Johannes Brug and Frans Nollet
    Citation: BMC Cancer 2010 10:671
  23. Genome-wide association studies and subsequent replication studies have shown that single nucleotide polymorphisms (SNPs) in the chromosomal region 8q24 are associated with colorectal cancer susceptibility.

    Authors: Carolyn M Hutter, Martha L Slattery, David J Duggan, Jill Muehling, Karen Curtin, Li Hsu, Shirley AA Beresford, Aleksandar Rajkovic, Gloria E Sarto, James R Marshall, Nazik Hammad, Robert Wallace, Karen W Makar, Ross L Prentice, Bette J Caan, John D Potter…
    Citation: BMC Cancer 2010 10:670
  24. A novel series of methylene-substituted DIMs (C-DIMs), namely 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes containing t-butyl (DIM-C-pPhtBu) and phenyl (DIM-C-pPhC6H5) groups inhibit proliferation of i...

    Authors: Kathy Vanderlaag, Yunpeng Su, Arthur E Frankel, Robert C Burghardt, Rola Barhoumi, Gayathri Chadalapaka, Indira Jutooru and Stephen Safe
    Citation: BMC Cancer 2010 10:669
  25. Activating transcription factor-3 (ATF3) is involved in the complex process of cellular stress response. However, its exact role in cancer is discussed controversially because both tumor suppressive and oncoge...

    Authors: Christina Hackl, Sven A Lang, Christian Moser, Akira Mori, Stefan Fichtner-Feigl, Claus Hellerbrand, Wolfgang Dietmeier, Hans J Schlitt, Edward K Geissler and Oliver Stoeltzing
    Citation: BMC Cancer 2010 10:668
  26. In this era of molecular targeting therapy when various systematic treatments can be selected, prognostic biomarkers are required for the purpose of risk-directed therapy selection. Numerous reports of various...

    Authors: Kazuhiro Namura, Ryogo Minamimoto, Masahiro Yao, Kazuhide Makiyama, Takayuki Murakami, Futoshi Sano, Narihiko Hayashi, Ukihide Tateishi, Hanako Ishigaki, Takeshi Kishida, Takeshi Miura, Kazuki Kobayashi, Sumio Noguchi, Tomio Inoue, Yoshinobu Kubota and Noboru Nakaigawa
    Citation: BMC Cancer 2010 10:667
  27. The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has been described for various solid tumors and their clinical relevance has been shown. CTC detection based on the anal...

    Authors: Eva Obermayr, Fatima Sanchez-Cabo, Muy-Kheng M Tea, Christian F Singer, Michael Krainer, Michael B Fischer, Jalid Sehouli, Alexander Reinthaller, Reinhard Horvat, Georg Heinze, Dan Tong and Robert Zeillinger
    Citation: BMC Cancer 2010 10:666
  28. Toll-like receptors (TLRs) have garnered an extraordinary amount of interest in cancer research due to their role in tumor progression. By activating the production of several biological factors, TLRs induce t...

    Authors: Salomé González-Reyes, Laura Marín, Lucía González, Luis O González, José M del Casar, Maria L Lamelas, José M González-Quintana and Francisco J Vizoso
    Citation: BMC Cancer 2010 10:665
  29. Although the invasive lobular carcinoma (ILC) is the second most frequent histologic subtype in Western countries, its incidence is much lower in Asia, and its characteristics are less well known.

    Authors: So-Youn Jung, Junsoo Jeong, Seung-Ho Shin, Youngmee Kwon, Eun-A Kim, Kyoung Lan Ko, Kyung Hwan Shin, Keun Seok Lee, In Hae Park, Seeyoun Lee, Seok Won Kim, Han-Sung Kang and Jungsil Ro
    Citation: BMC Cancer 2010 10:664
  30. The internet portal http://​www.​brustkrebs-studien.​de (BKS) was launched in 2000 by the German Society of Senology (DGS) and the Baden-Württemberg Insti...

    Authors: Markus Wallwiener, Christian W Wallwiener, Sara Y Brucker, Andreas D Hartkopf, Tanja N Fehm and Julia K Kansy
    Citation: BMC Cancer 2010 10:663
  31. Accurate staging of colorectal cancer (CRC) with clinicopathological parameters is important for predicting prognosis and guiding treatment but provides no information about organ site of metastases. Patterns ...

    Authors: Sjoerd C Bruin, Christiaan Klijn, Gerrit-Jan Liefers, Linde M Braaf, Simon A Joosse, Eric H van Beers, Victor J Verwaal, Hans Morreau, Lodewyk F Wessels, Marie-Louise F van Velthuysen, Rob AEM Tollenaar and Laura J van't Veer
    Citation: BMC Cancer 2010 10:662
  32. Boron neutron capture therapy (BNCT) is an alternative treatment modality for patients with glioma. The aim of this study was to determine whether induction of apoptosis contributes to the main therapeutic eff...

    Authors: Peng Wang, Haining Zhen, Xinbiao Jiang, Wei Zhang, Xin Cheng, Geng Guo, Xinggang Mao and Xiang Zhang
    Citation: BMC Cancer 2010 10:661
  33. Epidermal growth factor receptor inhibitor therapy is now approved for treatment of metastatic colorectal carcinomas (CRC) in patients with tumors lacking KRAS mutations. Several procedures to detect KRAS mutatio...

    Authors: Magnus Sundström, Karolina Edlund, Monica Lindell, Bengt Glimelius, Helgi Birgisson, Patrick Micke and Johan Botling
    Citation: BMC Cancer 2010 10:660
  34. Angiogenesis is important in the growth and metastasis of various kinds of solid tumors, including gastric cancers. The angiogenic process is triggered by several key growth factors, including vascular endothe...

    Authors: Shioto Suzuki, Yoh Dobashi, Yayoi Hatakeyama, Ryosuke Tajiri, Takashi Fujimura, Carl H Heldin and Akishi Ooi
    Citation: BMC Cancer 2010 10:659
  35. Preliminary studies suggest that physical exercise interventions can improve physical fitness, fatigue and quality of life in cancer patients after completion of chemotherapy. Additional research is needed to ...

    Authors: Caroline S Kampshoff, Laurien M Buffart, Goof Schep, Willem van Mechelen, Johannes Brug and Mai JM Chinapaw
    Citation: BMC Cancer 2010 10:658
  36. Coiled-coil domain containing 115 (Ccdc115) or coiled coil protein-1 (ccp1) was previously identified as a downstream gene of Fibroblast Growth Factor 2 (FGF2) highly expressed in embryonic and adult brain. Ho...

    Authors: Francesca Pellicano, Rachel E Thomson, Gareth J Inman and Tomoko Iwata
    Citation: BMC Cancer 2010 10:657
  37. the study was designed to determine how tumour hormone receptor status affects the subsequent pattern over time (dynamics) of breast cancer recurrence and death following conservative primary breast cancer res...

    Authors: Romano Demicheli, Ilaria Ardoino, Patrizia Boracchi, Danila Coradini, Roberto Agresti, Cristina Ferraris, Massimiliano Gennaro, William JM Hrushesky and Elia Biganzoli
    Citation: BMC Cancer 2010 10:656
  38. The five-year survival rates for head and neck squamous cell carcinoma (HNSCC) patients are less than 50%, and the prognosis has not improved, despite advancements in standard multi-modality therapies. Hence m...

    Authors: Muzafar A Macha, Ajay Matta, SS Chauhan, KW Michael Siu and Ranju Ralhan
    Citation: BMC Cancer 2010 10:655
  39. Basal-like breast cancers (BLBC) are aggressive breast cancers for which, so far, no targeted therapy is available because they typically lack expression of hormone receptors and HER2. Phenotypic features of B...

    Authors: Henne Holstege, Hugo M Horlings, Arno Velds, Anita Langerød, Anne-Lise Børresen-Dale, Marc J van de Vijver, Petra M Nederlof and Jos Jonkers
    Citation: BMC Cancer 2010 10:654
  40. Microarray gene-profiling of invasive breast cancer has identified different subtypes including luminal A, luminal B, HER2-overexpressing and basal-like groups. Basal-like invasive breast cancer is associated ...

    Authors: Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje and Fredrik Wärnberg
    Citation: BMC Cancer 2010 10:653
  41. Transforming growth factor β (TGFβ) receptor signaling is closely associated with the invasion ability of gastric cancer cells. Although Smad signal is a critical integrator of TGFβ receptor signaling transduc...

    Authors: Osamu Shinto, Masakazu Yashiro, Takahiro Toyokawa, Takafumi Nishii, Ryoji Kaizaki, Taro Matsuzaki, Satoru Noda, Naoshi Kubo, Hiroaki Tanaka, Yosuke Doi, Masaichi Ohira, Kazuya Muguruma, Tetsuji Sawada and Kosei Hirakawa
    Citation: BMC Cancer 2010 10:652
  42. Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combi...

    Authors: Gregor Habl, Alexandra D Jensen, Karin Potthoff, Matthias Uhl, Holger Hof, Jacek Hajda, Christian Simon, Jürgen Debus, Robert Krempien and Marc W Münter
    Citation: BMC Cancer 2010 10:651
  43. Human papillomavirus (HPV) infection is a major risk factor for the development of nearly all cases of cervical cancer worldwide. The presence of HPV DNA in cases of esophageal squamous-cell carcinoma (ESCC) h...

    Authors: Donghong Zhang, Qingying Zhang, Li Zhou, Leijun Huo, Yi Zhang, Zhongying Shen and Yi Zhu
    Citation: BMC Cancer 2010 10:650
  44. The DLX gene family encodes for homeobox transcription factors involved in the control of morphogenesis and tissue homeostasis. Their expression can be regulated by Endothelin1 (ET1), a peptide associated with br...

    Authors: Monica Morini, Simonetta Astigiano, Yorick Gitton, Laura Emionite, Valentina Mirisola, Giovanni Levi and Ottavia Barbieri
    Citation: BMC Cancer 2010 10:649
  45. Weight change during chemotherapy is reported to be associated with a worse prognosis in breast cancer patients, both with weight gain and weight loss. However, most studies were conducted prior to the common ...

    Authors: Emilie Thivat, Sophie Thérondel, Olivier Lapirot, Catherine Abrial, Pierre Gimbergues, Emilie Gadéa, Eloïse Planchat, Fabrice Kwiatkowski, Marie A Mouret-Reynier, Philippe Chollet and Xavier Durando
    Citation: BMC Cancer 2010 10:648
  46. Identification of urinary biomarkers for detection of bladder cancer recurrence would be beneficial to minimize the frequency of cystoscopy. Our objective was to determine the usability of urine content of mRN...

    Authors: Anne Sofie Brems-Eskildsen, Karsten Zieger, Helle Toldbod, Cherie Holcomb, Russell Higuchi, Francisco Mansilla, Pia P Munksgaard, Michael Borre, Torben F Ørntoft and Lars Dyrskjøt
    Citation: BMC Cancer 2010 10:646
  47. Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification aff...

    Authors: Patrizia Mancuso, Angelica Calleri, Pierluigi Antoniotti, Jessica Quarna, Giancarlo Pruneri and Francesco Bertolini
    Citation: BMC Cancer 2010 10:644

Featured videos

View featured videos from across the BMC-series journals